  
|
|
|
|
The Burroughs Wellcome Fund is an independent private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities.
Information about BWF and its award programs can be obtained by visiting our Web site at www.bwfund.org. To request a hard copy of a specific brochure to be delivered by U.S. mail, or to send a message to a program officer send an email message to info@bwfund.org.
BWF was founded in 1955 as the corporate foundation of the pharmaceutical firm Burroughs Wellcome Co. In 1993, a generous gift from BWF’s sister philanthropy in the United Kingdom, the Wellcome Trust, enabled the Fund to become fully independent from the company, which was acquired by Glaxo in 1995. The Burroughs Wellcome Fund has no affiliation with any corporation. BWF is governed by a board of directors composed of distinguished scientists and business leaders.
With its current endowment of more than $500 million, BWF provides approximately $25 million in grants annually in the United States and Canada. The Fund seeks to accomplish to primary goals through its programs - to help outstanding scientists early in their careers develop as independent investigators and to advance fields in the biomedical sciences that are undervalued or in need of particular encouragement. BWF’s financial support is channeled primarily through competitive peer-reviewed award programs, which encompass five major categories - career development of scientists, emerging infectious diseases, translational research, interfaces in science, and science education.
Last Modified: